INI1-negative tumors

Epizyme Beats Out the Market With FDA Approval
Yahoo/24-7 Wall St
Mon, 08/24/15 - 05:00 pm
FDA
Epizyme
tazemetostat
INI1-negative tumors
synovial sarcoma